Cisplatin 50mg

Cisplatin 50mg

Product Overview

Generic NameCisplatin 50mg
Brand Name(s)Platinol-AQ, Platinol, Cytoplatin
CategoryAntineoplastic / Cancer
FormVial, Intravenous injection (sterile aqueous solution)
Strength50 mg/50 mL
Therapeutic ClassPlatinum-based alkylating antineoplastic agent
ATC CodeL01XA01

Manufacturing & Regulatory

ManufacturerBristol-Myers Squibb, Accord Healthcare, Intas Pharma
GMP ComplianceWHO/cGMP-compliant
DMF/CEP#75-036
COFEPRIS010.000.6291.00
Free Sale CertificateYes

Logistics & Export

MOQ10 units
Shelf Life24 months
Storage2–8 °C
IncotermsEx-Works Mexico
Lead Time7 to 10 Days

Documentation Available Upon Request

Certificate of Analysis (PDF)Yes
SDS-Safety Data Sheet (PDF)Upon Request
CTD Summary (PDF)CTD from originator; generic use abbreviated formats

Special Notes

Cisplatin is an injectable platinum-based chemotherapy medicine used under specialist oncology supervision for the treatment of several solid tumors, including testicular, ovarian, bladder, lung, cervical, and head-and-neck cancers. It is administered by intravenous infusion and requires close monitoring due to potential kidney toxicity, bone marrow suppression, hearing toxicity, nausea/vomiting, and electrolyte abnormalities.